Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes

Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes

    Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes Jameel Lone, Jae Heon Choi, Sang Woo Kim, Jong Won Y...

1MB Sizes 1 Downloads 56 Views

    Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes Jameel Lone, Jae Heon Choi, Sang Woo Kim, Jong Won Yun PII: DOI: Reference:

S0955-2863(15)00241-7 doi: 10.1016/j.jnutbio.2015.09.006 JNB 7452

To appear in:

The Journal of Nutritional Biochemistry

Received date: Revised date: Accepted date:

29 June 2015 1 September 2015 3 September 2015

Please cite this article as: Lone Jameel, Choi Jae Heon, Kim Sang Woo, Yun Jong Won, Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes, The Journal of Nutritional Biochemistry (2015), doi: 10.1016/j.jnutbio.2015.09.006

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT Regular article for submission to Journal of Nutritional Biochemistry (Revised manuscript)

RI P

T

Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes

SC

Jameel Lone†, Jae Heon Choi†, Sang Woo Kim, Jong Won Yun

MA NU

Department of Biotechnology, Daegu University, Kyungsan, Kyungbuk 712-714,



AC

CE

PT

ED

Republic of Korea

These authors contributed equally to this work.

Correspondence to: Dr. Jong Won Yun Department of Biotechnology, Daegu University, Kyungsan, Kyungbuk 712-714, Republic of Korea. E-mail: [email protected]; Fax: +82-53-850-6559

1

ACCEPTED MANUSCRIPT Abstract Recent advances have been made in the understanding of pharmacological and dietary agents

RI P

T

that contribute to browning of white adipose tissue in order to combat obesity by promoting energy expenditure. Here, we show that curcumin induces browning of 3T3-L1 and primary

SC

white adipocytes via enhanced expression of brown fat-specific genes. Curcumin-induced browning in white adipocytes was investigated by determining expression levels of brown

MA NU

adipocyte-specific genes/proteins by real-time RT-PCR, immunoblot analysis, and immunocytochemical staining. Curcumin increased mitochondrial biogenesis, as evidenced by transmission electronic microscopic detection and enhanced expression of proteins involved in fat oxidation. Cucurmin also increased protein levels of HSL and p-ACC,

ED

suggesting its possible role in augmentation of lipolysis and suppression of lipogenesis.

PT

Increased expression of UCP1 and other brown adipocyte-specific markers was possibly mediated by curcumin-induced activation of AMPK based on the fact that inhibition of

CE

AMPK by dorsomorphin abolished expression of PRDM16, UCP1, and PGC-1α while the activator AICAR elevated expression of these brown marker proteins. Our findings suggest

AC

that curcumin plays a dual modulatory role in inhibition of adipogenesis as well as induction of the brown fat-like phenotype and thus may have potential therapeutic implications for treatment of obesity.

Keywords: Anti-obesity; Curcumin; adipocyte browning; Non-shivering thermogenesis; UCP1

1

ACCEPTED MANUSCRIPT

Abbreviations ACC, acyl-CoA carboxylase; AMPK, AMP-activated protein kinase; Brite, brown in white;

T

BAT, brown adipose tissue; CYT C, cytochrome C; C/EBP/Cebp, CCAAT/enhancer-binding

RI P

protein/encoding gene; CPT, carnitine palmitoyltransferase; Fgf21, gene encoding fibroblast growth factor 21; HSL, hormone-sensitive lipase; PGC-1α, peroxisome proliferator-activated

SC

receptor gamma co-activator 1-alpha; PPAR, peroxisome proliferator-activated receptor; PRDM16/Prdm16, PR domain-containing 16/encoding gene; UCP1/Ucp1, uncoupling

AC

CE

PT

ED

MA NU

protein 1/encoding gene; WAT, white adipose tissue.

2

ACCEPTED MANUSCRIPT 1 Introduction Obesity develops when energy intake exceeds energy expenditure [1] and is mainly

T

characterized by excessive deposition of adipose tissues [2, 3]. Restriction of caloric intake is

RI P

considered to be first line defense against obesity, but this strategy does not help people with dysfunctional development of brown fat tissue, which dissipates surplus calorie intake into

SC

heat energy via a process known as non-shivering thermogenesis [4, 5]. In this regard,

MA NU

browning of white adipocytes is considered as an alternative strategy against diet-induced obesity. After the recent finding of brown adipose tissue (BAT) in adult human subjects, strategies for combating obesity have shifted from preventing fat accumulation to promoting energy expenditure by activation of BAT and browning of white adipose tissue (WAT) [6, 7].

ED

In this sense, induction of white fat browning represents an attractive potential strategy for the treatment of obesity and related complications.

PT

Although brown and white adipocytes originate from different cell lineages and each

CE

lineage has a different progenitor, they are readily interconvertable to each other [8]. Expression of UCP1 in multilocular cells with thermogenic capability to develop in white fat

AC

depots with some external stimuli is being characterized as beige or brite (brown in white) [9]. This UCP1-driven heat dissipation is known as adaptive thermogenesis [10]. UCP1 uncouples the electron transport chain from energy production, resulting in release of heat energy [11]. Cold exposure and pharmacological activation of β3-adrenergic receptors are key factors in the appearance of brite adipocytes in WAT via promotion of WAT remodeling by adipocyte progenitors [12, 13]. Ectopic expression of hallmark proteins for brown adipocytes such as UCP1 and PGC-α in white adipocytes induces acquisition of BAT features [14, 15]. More recent studies identified novel brite-specific markers such as PRDM16 that have been targeted for identification of brown fat-stimulating agents [16, 17]. 3

ACCEPTED MANUSCRIPT Recent advances have been made in the understanding of pharmacological and dietary agents that contribute to browning of WAT, and a number of dietary compounds have been

T

proposed as tools for increasing energy expenditure and decreasing fat accumulation in

RI P

mammals [18-19], including capsaicin, berberine, orexin, and irisin [19-22]. Here, we found that curcumin induces browning in both white adipocytes-derived 3T3-L1 cells and primary

SC

white adipocytes from rats.

MA NU

Curcumin is a naturally occurring curcuminoid of turmeric, which is a member of the ginger family (Zingiberaceae) and perhaps one of the most studied medicinal herbs [23]. Curcumin has diverse beneficial effects ranging from anti-cancerous and anti-inflammatory activities to behavioral improvement in Alzheimer’s disease [24-28]. Dietary curcumin

ED

administration was reported to prevent weight gain in rodent animal models. For example, curcumin plays an anti-inflammatory role in obesity and obesity-related metabolic disorders

PT

[29] and directly interacts with WAT to suppress chronic inflammation [30]. Moreover, it was

CE

reported that curcumin administration can prevent HFD-induced obesity and insulin resistance by arresting lipogenesis in the liver and the inflammatory pathway in adipocytes as

AC

well as reduce blood glucose levels by enhanced expression of glucose transporters in mice and humans [31, 32]. Curcumin also inhibits adipocyte differentiation and adipogenesis in cultured adipocytes with concentration of 5~30 μM [33, 34]. However, despite its demonstrated effects, the potential health benefits of curcumin have been limited due to its poor solubility, rapid metabolism, and rapid systemic elimination [35, 36]. Therefore, numerous approaches have been undertaken to improve bioavailability of curcumin [37, 38]. To date, the browning effect of curcumin in white adipcotes with respect to obesity has not been reported. The present study therefore investigated the effect of curcumin on induction of brite phenotype in cultured white adipocytes. To this end, we used two different 4

ACCEPTED MANUSCRIPT white adipocyte cell models, 3T3-L1 and primary white adipocytes isolated from inguinal

T

WAT of rats.

RI P

2 Materials and methods

MA NU

SC

2.1 Cell culture and differentiation

Dulbecco’s Modified Eagle’s Medium (DMEM, Thermo, Waltam, MA, USA) supplemented with 10% fetal bovine serum (FBS, PAA Laboratories, Pasching, Austria) and 100 µg/ml of penicillin-streptomycin (Invitrogen, Carlsbad, CA, USA) was used to culture 3T3-L1

ED

preadipocytes (ATCC, Manassas, VA, USA) at 37ºC in a 5% CO2 incubator. Sufficiently confluent cells were maintained in differentiation induction medium consisting of 10 µg/ml

PT

of insulin (Sigma, St. Louis, MO, USA), 0.25 µM dexamethasone (Sigma), and 0.5 mM 3-

CE

isobutyl-1-methylxanthine (IBMX, Sigma) in DMEM, followed by maturation medium containing 10% FBS and 10 µg/ml of insulin. During treatments, unless otherwise stated,

AC

cells were maintained in complete medium containing 20 µM curcumin 6-8 days before further analysis, and maturation medium was changed every 2 days. The range of curcumin doses (1~20 μM) used in this study was determined based on previous report [33]. Ten-days-old rats were used for the isolation of primary adipocytes by using a previously described method [39]. In brief, inguinal fat pads were minced with scissors and digested with type I collagenase (1 mg/ml; Sigma-Aldrich) at 37°C in a water bath shaker. After 90 min, contents were immediately filtered through mesh and centrifuged at 1,000×g for 10 min. Animal experiments were performed (under project identification code, DUIACC-2014-3-0321-001) with the consent of the Advisory Committee for Laboratory 5

ACCEPTED MANUSCRIPT Animal Care and Use of Daegu University. The layer of floating cells was then washed three times with PBS. Adipocytes were incubated in Dulbecco’s modified Eagle’s medium

T

(DMEM) supplemented with 10% FBS and 100 units/ml of penicillin-streptomycin (Sigma-

RI P

Aldrich) under a 5% CO2 atmosphere at 37°C. After confluence (day 1), cells were initiated for adipocyte differentiation by incubation with differentiation induction medium. For

SC

treatment of browning cocktail and curcumin, differentiation induction medium was

MA NU

supplemented with 50 nM triidothyronine, and maturation medium was supplemented with 50 nM triidothyronine with 1 μM rosiglitazone. To test the effects of AICAR and dorsomprphin, AICAR (1 mM) or dorsomorphin (5 µM) was added to the differentiation

ED

induction and maturation media until cells were harvested.

PT

2.2 Oil Red O staining

CE

Control and curcumin-treated cells were matured for 4-8 days, followed by washing with phosphate-buffered saline (PBS), fixation with 10% formalin for 1 h at room temperature,

AC

and washing again three times with deionized water. A mixture of Oil Red O solution (0.6% Oil Red O dye in isopropanol) and water in a 6:4 ratio was layered onto cells for 20 min, followed by washing four times with deionized water, and images were captured under a microscope.

2.3 Immunofluorescence

Cells grown on poly-L-lysine-pretreated coverslips were fixed with 4% p-formaldehyde followed by washing with PBS and then subjected to permeabilization with 0.25% Triton X6

ACCEPTED MANUSCRIPT 100 (Sigma). Cells were washed with PBS three times, blocked with 1% BSA in PBS-T for 1 h, and incubated with polyclonal anti-UCP1 antibody (1:200 dilution) (Santa Cruz

T

Biotechnology, Santa Cruz, CA, USA) overnight at 4°C, followed by three washes with PBS.

RI P

Cells were then incubated with FITC-conjugated anti-goat secondary antibody (1:400 dilutions). DAPI (Invitrogen) was used to stain nuclei of cells. Florescence images were

SC

captured using a confocal laser scanning microscope LSM700 (Carl Zeiss, Oberkochen

MA NU

Germany). Analysis of images (control and curcumin-treated) was performed by software Zen 2009 (Carl Zeiss). For staining of mitochondria, Mito® Tracker Red (1 mM, Cell Signaling Technology, Beverly, MA, USA) was directly added to the growing media at a concentration of 20-25 nM, and cells were kept for 30-40 min at 37°C. After incubation, cells

PT

ED

were fixed in 4% p-formaldehyde, followed by a single wash with PBS and immunostaining.

CE

2.4 Quantitative real-time RT-PCR

AC

Total RNA was isolated from matured cells (4-8 days) using a total RNA isolation kit (RNAspin, iNtRON Biotechnology, Seongnam, Korea). RNA (1 μg) was converted to cDNA using Maxime RT premix (iNtRON Biotechnology). Power SYBR green (Roche Diagnostics Gmbh, Mannheim, Germany) was employed to quantitatively determine transcript levels of genes with RT-PCR (Stratagene 246 mix 3000p QPCR System, Agilent Technologies, Santa Clara, CA, USA). PCR reactions were run in duplicate for each sample, and transcript levels of every gene were normalized to the level of β-actin. Sequences of primer sets used in this study are listed in Table 1.

7

ACCEPTED MANUSCRIPT 2.5 Immunoblot analysis

T

Cell lysates were prepared using RIPA buffer (Sigma) by homogenization and centrifugation

RI P

at 14,000 ×g for 20 min. Cell extract was diluted in 5X sample buffer (50 mM Tris at pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.1% bromophenol blue) and heated for

SC

5 min at 95C before 8, 10, or 12% SDS-polyacrylamide gel electrophoresis (PAGE). After

MA NU

electrophoresis, samples were transferred to a polyvinylidene difluoride membrane (PVDF, Santa Cruz Biotechnology) and then blocked for 1 h with TBS-T (10 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween 20) containing 5% skim milk. The membrane was rinsed three times consecutively with TBS-T buffer, followed by incubation for 1 h with 1:1,000 dilutions of

ED

primary monoclonal antibodies, anti-β-actin, anti-PPARγ, anti-AMPK, and anti-p-AMPK, anti-PRDM16, anti-UCP1, anti-PGC-1α, anti-C/EBPβ, anti-CPT1, anti-CYT C, anti-HSL

PT

(Santa Cruz Biotechnology), and anti-p-ACC (Cell Signaling Technology), in TBS-T buffer

CE

containing 1% skim milk. After three washes, the membrane was incubated for 1 h with horseradish peroxidase-conjugated anti-goat IgG or anti-rabbit IgG secondary antibody

AC

(1:1000, Santa Cruz Biotechnology) in TBS-T buffer containing 1% skim milk. Development was carried out using enhanced chemiluminescence (WEST-ZOL, iNtRON Biotechnology). Quantification of band intensities was performed by using ImageJ software (NIH).

2.6 Transmission electron microscopy

3T3-L1 and primary adipocytes were washed with 0.1 M phosphate buffer and fixed in 2.5% (w/v) glutaraldehyde solution overnight at 4°C. Then, cells were post-fixed in 1% (w/v) osmium tetraoxide, dehydrated in ascending gradations of ethanol, and embedded in fresh 8

ACCEPTED MANUSCRIPT epoxy resin. Ultra-thin sections (70-80 nm) were cut and stained with uranyl citrate and lead citrate before being examined under a transmission electron microscope H-7600 (Hitachi,

RI P

T

Tokyo, Japan).

SC

2.7 Statistical analysis

MA NU

All data were expressed as the mean ± SD, and comparison was made by using One-way ANOVA using the Statistical Package of Social Science (SPSS, version 17.0; SPSS Inc., Chicago, IL, USA) program, followed by Tukey’s post hoc tests. Statistical significances between control, cocktail, and curcumin-treated groups were indicated as either p<0.05

ED

or p<0.01.

CE

PT

3 Results

AC

3.1 Curcumin induces browning of 3T3-L1 and primary white adipocytes

To investigate the browning effect of curcumin, 3T3-L1 and primary inguinal adipocytes from rats were used as cellular models and treated with different concentrations of curcumin (1~20 μM). Curcumin significantly increased brown fat markers (PGC-1α, PPARγ, and UCP1) in both adipocytes in a dose-dependent manner (Fig. 1). Next, both adipocytes were treated with a browning cocktail (rosiglitazone and triidothyronine) with and without curcumin, after which expression levels of brown fat-specific genes were determined. As shown in Fig. 2, curcumin treatment in both adipocytes resulted in rapid up-regulation of brown fat-specific genes against vehicle and positive control (cocktail group). The enhanced 9

ACCEPTED MANUSCRIPT expression of brown fat markers, including UCP1, PGC-1α, PRDM16, and C/EBPβ as well as Tmem26, Cidea, Fgf21, and Cited1, suggests possible conversion of white adipocytes into

T

beige cells. Increased expression of key brown cell marker proteins (C/EBPβ, PGC-1α,

RI P

PRDM16, and UCP1) was further confirmed by Western blot analysis (Fig. 2B). In addition, enhanced expression of UCP1 upon curcumin treatment was confirmed at the cellular level

MA NU

SC

by immunostaining (Fig. 3).

3.2 Curcumin induces mitochondrial biogenesis

To judge whether curcumin increases mitochondrial biogenesis, which is a marked feature of

ED

fat browning, transmission electronic microscopic study was conducted. As shown in Fig. 4A, density of mitochondria was markedly elevated in both curcumin-treated adipocytes, and this

PT

was further confirmed by a Mito® Tracker Red that specifically binds to mitochondria (Fig. 3).

CE

The increased mRNA and protein levels of PGC-1α, a key player in mitochondrial biogenesis, also support these results (Fig. 2). Taken together, curcumin drives thermogenic programming,

AC

thereby increasing the brown fat phenotype along with mitochondrial biogenesis.

3.3 Curcumin regulates lipid metabolism in adipocytes

We investigated whether curcumin increases lipolysis and fat oxidation in both adipocytes. Our data demonstrate that curcumin treatment led to significant elevation of mitochondrial CPT1 and cytochrome C protein levels, suggesting enhanced fat oxidation upon curcumin treatment (Fig. 4A). Moreover, increased expression levels of HSL and p-ACC reflect augmented lipolysis and suppressed fatty acid synthesis, respectively (Fig. 4B). In addition, 10

ACCEPTED MANUSCRIPT small lipid droplet numbers, as visualized by Oil Red O staining, increased upon curcumin

T

treatment (Fig. 4C).

RI P

3.4 Curcumin induces brown fat phenotype via AMPK-mediated pathway

SC

To identify the possible mechanism underlying the browning effect of curcumin, we

MA NU

determined expression levels of AMPK, a metabolic master switch regulating fatty acid utilization and energy homeostasis. Curcumin treatment significantly increased expression levels of both total AMPK and phosphorylated AMPK (p-AMPK) as well as the ratio of pAMPK to AMPK (Fig. 5). These results drove us to hypothesize that curcumin induces the

ED

brown fat phenotype via the AMPK-mediated pathway. To test this hypothesis, we treated both adipocytes with AICAR (1 mM) or dorsomorphin (5 mM), which are a potent activator

PT

and inhibitor of AMPK, respectively. Inhibition of AMPK by dorsomorphin abolished

CE

expression of UCP1, PRDM16, and PGC-1α while the activator AICAR elevated expression of these brown marker proteins (Fig. 6). These expression patterns suggest that curcumin

AC

increases expression of hallmark proteins for brown adipocytes in both adipocytes via a mechanism involving AMPK and PGC-1α.

4 Discussion

Strategies that manipulate WAT to acquire BAT-like characteristics are a promising approach to help, prevent and manage obesity [40]. The present study provides insights into the role of dietary curcumin in inducing the brown fat phenotype in 3T3-L1 and primary white adipocytes. We successfully demonstrated that curcumin along with a browning cocktail 11

ACCEPTED MANUSCRIPT could synergistically induce the brite phenotype and drive the BAT thermogenic program through significant elevation of brown fat-specific genes such as Fgf21, Cidea, Tmem26, and

T

Tbx1 as well as proteins such as UCP1, PGC-1α, and PRDM16. It was demonstrated that

RI P

Tmem26 and Tbx1 are brown fat-specific markers, and brite cells are highly enriched in these two markers [41]. Our results show that curcumin significantly elevated expression of both

SC

genes, suggesting a possible role for curcumin in inducing the brite phenotype. Our data also

MA NU

strongly demonstrate that curcumin significantly up-regulated UCP1, a hallmark protein of brown adipocytes, at both mRNA and protein levels. Enhanced protein levels of UCP1 was accompanied by elevated expression of PRDM16, a master regulator of BAT development [42].

ED

Elevation of mitochondrial numbers is a characteristic feature of fat browning [17]. Current data demonstrate that curcumin increased mitochondrial biogenesis, as evidenced by

PT

transmission electronic microscopic detection as well as elevated expression of PGC-1α, a

CE

master regulator of mitochondrial biogenesis and function. Ectopic expression of PGC-1α in white adipocytes induces acquisition of BAT features, including expression of thermogenic

AC

markers. Our data also support an increased number of mitochondria and elevated expression of PGC-1α, which also acts as a cold inducible protein governing the adaptive thermogenic process [43]. In addition, curcumin treatment led to increased expression of important mitochondrial proteins such as CPT1 and cytochrome C. It is well recognized that CPT1 increases mitochondrial activity and enhances fatty acid oxidation in brown adipocytes [44]. Cytochrome C also plays a key role in mitochondrial oxidative phosphorylation and is considered to be highly enriched in brown fat cells [45, 46]. Therefore, enhanced expression of these two proteins is likely to reflect the stimulatory action of curcumin with regard to fat 12

ACCEPTED MANUSCRIPT oxidation. Curcumin also appears to stimulate lipolysis and suppress lipogenesis, as it increased expression levels of HSL and p-ACC [47]. HSL is the key enzyme of lipolysis [48],

T

whereas phosphorylation of ACC (p-ACC) results in reduction of ACC enzyme, which is the

RI P

rate-limiting enzyme in fatty acid synthesis [49]. Moreover, our data show that curcumintreated adipocytes contained a greater number of small lipid droplets, which provide a greater

SC

surface area for the actions of water-soluble lipolytic enzymes [40].

MA NU

Activation of the AMPK-mediated pathway is pivotal in maintaining energy homeostasis [50]. Our data show that curcumin significantly increased expression of AMPK and its activated form (p-AMPK), and its effect was totally abolished upon inhibition of AMPK. The role of AMPK in browning of white adipocytes has been very controversial. For example,

ED

some studies have reported that browning of white adipocytes is accompanied with increased expression of AMPK and its phosphorylation [51, 52]. In contrast, it was demonstrated that

PT

only activation of AMPK takes places but total AMPK level remains constant during the

CE

process of browning event [53]. Hutchinson et al. have reported that AMPK level increases in fully differentiated primary brown adipocytes [54]. To identify its role in the curcumin-

AC

induced browning pathway, we treated adipocytes with AICAR, a potent activator of AMPK, as well as dorsomorphin, a selective inhibitor of AMPK. Curcumin treatment resulted in higher expression of activated AMPK, which indicates that the effects of curcumin are mediated via AMPK. Arrest of brown fat expression marker proteins upon AMPK inhibition reinforces our conclusion that curcumin induces browning via the AMPK-mediated pathway. Shan et al. [50] indicated that the AMPK-PGC1α-Fndc5 pathway drives browning of WAT. Similarly, other natural compounds such as berberine and resvervatol were found to induce browning of white adipocytes through AMPK activation [20, 52]. Taken together, the AMPKmediated pathway plays a pivotal role in induction of browning and stimulation of the 13

ACCEPTED MANUSCRIPT thermogenic program in adipocytes [47]. Although AMPK is a key regulator in browning event, the accurate molecular mechanisms by which AMPK is activated during browning of

T

white adipocytes remain to be demonstrated. It should be mentioned that current in vitro data

RI P

may not guarantee positive results in either animal or human study as oral dose of curcumin show very low plasma levels [33]. Hence, new formulation strategy may be required to

SC

increase absorption of curcumin.

MA NU

In conclusion, our findings suggest that curcumin plays a dual modulatory role in inhibition of lipogenesis as well as induction of the brown-like phenotype, thereby displaying potential therapeutic implications for the treatment of obesity. Although our in vitro data obtained from both 3T3-L1 and primary white adipocytes suggest that curcumin significantly

ED

induces fat browning, an in vivo study is required to solidify its role.

CE

PT

(Acknowledgements) This work was supported by the Mid-career Researcher Program (2013R1A2A2A05004195) and SRC Program (Center for Food & Nutritional Genomics, Grant number 2015R1A5A6001906) through NRF grant funded by the Ministry of Science, ICT and Future Planning, Korea.

AC

(Conflicting interests) The authors declared no conflicts of interest.

14

ACCEPTED MANUSCRIPT 5 References

T

[1] Tseng YH, Cypess AM, Kahn CR. Cellular bioenergetics as a target for obesity t

RI P

herapy. Nat Rev Drug Discov 2010;9:465-82.

SC

[2] Park KW, Halperin DS, Tontonoz P. Before they were fat: adipocyte progenitors.

MA NU

Cell Metab 2008;8:454-7.

[3] Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to it s source. Cell 2007;131:242-56.

ED

[4] Harms M, Seale P. Brown and beige fat: development, function and therapeutic p

PT

otential. Nat Med 2013;19:1252-63.

CE

[5] van der Lans AA, Hoeks J, Brans B, Vijgen GH, Visser MG, Vosselman MJ, et a

AC

l. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis . J Clin Invest 2013;123:3395-403.

[6] Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. Fun ctional brown adipose tissue in healthy adults. N Eng J Med 2009;360:1518-25.

[7] van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Ke merink GJ, Bouvy ND, et al. Cold-activated brown adipose tissue in healthy men. N Eng J Med 2009;360:1500-8.

15

ACCEPTED MANUSCRIPT [8] Rosenwald M, Perdikari A, Rulicke T, Wolfrum C. Bi-directional interconversion o

T

f brite and white adipocytes. Nat Cell Biol 2013;15:659-67.

RI P

[9] Lim S, Honek J, Xue Y, Seki T, Cao Z, Andersson P, et al. Cold-induced activati on of brown adipose tissue and adipose angiogenesis in mice. Nat Protoc 2012;7:606-

MA NU

SC

15.

[10] Sellayah D, Sikder D. Orexin restores aging-related brown adipose tissue dysfunc tion in male mice. Endocrinology 2014;155:485-501.

ED

[11] Ricquier D. Uncoupling protein 1 of brown adipocytes, the only uncoupler: a his

PT

torical perspective. Front Endocrinol 2011;2:85.

CE

[12] Calvani R, Leeuwenburgh C, Marzetti E. Brown adipose tissue and the cold war

AC

against obesity. Diabetes 2014;63:3998-4000.

[13] Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell 2012;150:62032.

[14] Tiraby C, Tavernier G, Lefort C, Larrouy D, Bouillaud F, Ricquier D, et al. Acq uirement of brown fat cell features by human white adipocytes. J Biol Chem 2003;27 8:33370-6.

16

ACCEPTED MANUSCRIPT [15] Sharp LZ, Shinoda K, Ohno H, Scheel DW, Tomoda E, Ruiz L, et al. Human B AT possesses molecular signatures that resemble beige/brite cells. PLoS One 2012;7:e4

RI P

T

9452.

[16] Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, et al. FGF2

SC

1 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogene

MA NU

sis. Genes Dev 2012;26:271-81.

[17] Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, et al. Prdm1 6 determines the thermogenic program of subcutaneous white adipose tissue in mice.

ED

J Clin Invest 2011;121:96-105.

PT

[18] Bonet ML, Oliver P, Palou A. Pharmacological and nutritional agents promoting

CE

browning of white adipose tissue. Biochim Biophys Acta 2013;1831:969-85.

AC

[19] Baboota RK, Singh DP, Sarma SM, Kaur J, Sandhir R, Boparai RK, et al. Caps aicin induces "brite" phenotype in differentiating 3T3-L1 preadipocytes. PLoS One 201 4;9:e103093.

[20] Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Berberine, a nat ural plant product, activates AMP-activated protein kinase with beneficial metabolic eff ects in diabetic and insulin-resistant states. Diabetes 2006;55:2256-64.

[21] Sellayah D, Bharaj P, Sikder D. Orexin is required for brown adipose tissue dev 17

ACCEPTED MANUSCRIPT elopment, differentiation, and function. Cell Metab 2011;14:478-90.

T

[22] Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates brow

RI P

ning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase an

SC

d ERK MAP kinase signaling. Diabetes 2014;63:514-25.

Y Acad Sci 2005;1056:206-17.

MA NU

[23] Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N

[24] Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumi

ED

n. Adv Exp Med Biol 2007;595:105-25.

PT

[25] Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's diseas

CE

e: An overview. Ann Indian Acad Neurol 2008;11:13-9.

AC

[26] Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Cur cuma longa: a review of preclinical and clinical research. Altern Med Rev 2009;14:14 1-53.

[27] Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, et al. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem 2014;25:177-85.

[28] Hishikawa N, Takahashi Y, Amakusa Y, Tanno Y, Tuji Y, Niwa H, et al. Effects 18

ACCEPTED MANUSCRIPT of turmeric on Alzheimer's disease with behavioral and psychological symptoms of d

T

ementia. Ayu 2012;33:499-504.

RI P

[29] Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti-inflammator y role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr 2011;

MA NU

SC

50:151-61.

[30] Bradford PG. Curcumin and obesity. BioFactors 2013;39:78-87.

[31] Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, et al. Curcumin prevents hi

ED

gh fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver a

PT

nd inflammatory pathway in adipocytes. PLoS One 2012;7:e28784.

CE

[32] Ghorbani Z, Hekmatdoost A, Mirmiran P. Anti-hyperglycemic and insulin sensitiz er effects of turmeric and its principle constituent curcumin. Int J Endocrinol Metab 2

AC

014;12:e18081.

[33] Kim CY, Le TT, Chen C, Cheng JX, Kim KH. Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J Nutr Biochem 2011;22: 910-20.

[34] Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 2009;139:919-25.

19

ACCEPTED MANUSCRIPT [35] Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curc

T

umin: problems and promises. Mol Pharm 2007;4:807-18.

RI P

[36] Jäger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparativ

SC

e absorption of curcumin formulations. Nutr J 2014;13-11.

MA NU

[37] Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction a nd glucuronidation in mice. Drug Metab Dispos 1999;27:486-94.

[38] Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumi

ED

n in rats. Toxicology 1980;16:259-65.

PT

[39] Hausman DB, Park HJ, Hausman GJ. Isolation and culture of preadipocytes from rodent

CE

white adipose tissue. Methods Mol Biol 2008;456:201-19.

AC

[40] Townsend KL, Tseng YH. Brown fat fuel utilization and thermogenesis. Trends Endocrinol Metab 2014;25:168-77.

[41] Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, et al. Beige adipocyte s are a distinct type of thermogenic fat cell in mouse and human. Cell 2012;150:36676.

[42] Villena JA, Carmona MC, Rodriguez de la Concepcion M, Rossmeisl M, Vinas O, Mampel T, et al. Mitochondrial biogenesis in brown adipose tissue is associated w 20

ACCEPTED MANUSCRIPT ith differential expression of transcription regulatory factors. Cell Mol Life Sci 2002;5

T

9:1934-44.

RI P

[43] Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1alpha, a nodal regulator of

SC

mitochondrial biogenesis. Am J Clin Nutr 2011;93:884S-90S.

MA NU

[44] Townsend KL, An D, Lynes MD, Huang TL, Zhang H, Goodyear LJ, et al. Incr eased mitochondrial activity in BMP7-treated brown adipocytes, due to increased CPT 1- and CD36-mediated fatty acid uptake. Antioxid Redox Signal 2013;19:243-57.

ED

[45] Seale P, Kajimura S, Yang W, Chin S, Rohas LM, Uldry M, et al. Transcription

PT

al control of brown fat determination by PRDM16. Cell Metab 2007;6:38-54.

CE

[46] Lu RH, Ji H, Chang ZG, Su SS, Yang GS. Mitochondrial development and the i

2173-82.

AC

nfluence of its dysfunction during rat adipocyte differentiation. Mol Biol Rep 2010;37:

[47] Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014;25:1-18.

[48]

Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated

multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011;50:14-27.

21

ACCEPTED MANUSCRIPT [49] Kim KH. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu Rev N

T

utr 1997;17:77-99.

SC

whole organism. Int J Obes (Lond) 2008;32:S7-S12.

RI P

[50] Hardie DG. AMPK: a key regulator of energy balance in the single cell and the

MA NU

[51] Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FA SEB J 2013; 27:1981-9.

ED

[52] Zhang Z, Zhang H, Li B, Meng X, Wang J, Zhang Y, et al. Berberine activates

PT

thermogenesis in white and brown adipose tissue. Nat Commun 2014;5:5493.

CE

[53] Wang S, Liang X, Yang Q, Fu X, Rogers CJ, Zhu M, et al. Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated prot

AC

ein kinase (AMPK) alpha1. Int J Obes (Lond) 2015;39:967-76.

[54] Hutchinson DS, Chernogubova E, Dallner OS, Cannon B, Bengtsson T. Betaadrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 2005;48:2386-95.

22

ACCEPTED MANUSCRIPT Table 1. The primary sequence used for real-time quantitative PCR 3T3-L1 Forward

Reverse

Cidea

CGGGAATAGCCAGAGTCACC

TGTGCATCGGATGTCGTAGG

Fgf21

CGTCTGCCTCAGAAGGACTC

TCTACCATGCTCAGGGGGTC

Prdm16

GATGGGAGATGCTGACGGAT

TGATCTGACACATGGCGAGG

Tmem26

GAAACCAGTATTGCAGCACCC

Tbx1

CGAATGTTCCCCACGTTCCA

Ucp1

CCTGCCTCTCTCGGAAACAA

SC

RI P

T

Gene

CCAGACCGGTTCACATACCA GTCTACTCGGCCAGGTGTAG

MA NU

GTAGCGGGGTTTGATCCCAT

Primary

GACTTCCTCGGCTGTCTCAA

GAACCGCAGCAGACTCCTTA

Fgf21

CTCCAGTTTGGGGGTCAAGT

GGAGACTTTCTGGACTGCGG

Prdm16

AGAGGATGAGGAACCACCCA

AAATGCTTCCTCAGCTGCTCT

Pparγ

CCTCTCCGTGATGGAAGACC

CCATTGGGTCAGCTCTTGTG

Pgc1α

ATGTGTCGCCTTCTTGCTCT

ATCTACTGCCTGGGGACCTT

Tmem26

AAGATGGCCCCTTCCTTGTG

ATCAAAGCCACAAGCCGGTA

Ucp1

AATCAGCTTTGCTTCCCTCA

GCTTTGTGCTTGCATTCTGA

AC

CE

PT

ED

Cidea

23

ACCEPTED MANUSCRIPT Figure captions

Figure 1. Dose-dependent effect of curcumin on expression of brown fat-specific markers.

T

Different doses of curcumin (1, 10, and 20 μM) were treated to 3T3-L1 and primary white

RI P

adipocytes of rats, followed by measurement of protein expression by densitometric analysis. All data are presented as the mean ±SD, and differences between groups were determined by

SC

One-way Analysis of Variance (ANOVA) using the Statistical Package of Social Science (SPSS, version 17.0; SPSS Inc., Chicago, IL, USA) program, followed by Tukey’s post hoc tests. Statistical significance between control and curcumin-treatment groups was shown as p<0.05 and **p<0.01; between cocktail and curcumin-treated groups was depicted as †p<0.05

MA NU

*

and ††p<0.01; between control and cocktail was noted as #p<0.05 and ##p<0.01.

Figure 2. Effect of curcumin on expression of brown fat-specific genes and proteins in 3T3L1 and primary white adipocytes. Both adipocytes of rats were treated with 20 μM curcumin,

ED

and expression levels of brite cell-specific markers were measured by RT-PCR (A). Protein expression was measured by Western blotting and quantified by densitometric analysis (B).

PT

Relative intensity (%) of mRNA and proteins were normalized with β-actin. All data are presented as the mean ±SD, and differences between groups were determined by One-way

CE

Analysis of Variance (ANOVA) using the Statistical Package of Social Science (SPSS, version 17.0; SPSS Inc., Chicago, IL, USA) program, followed by Tukey’s post hoc tests.

AC

Statistical significance between control and curcumin-treatment groups was shown as p<0.05 and **p<0.01; between cocktail and curcumin-treated groups was depicted as †p<0.05

*

and ††p<0.01; between control and cocktail was noted as #p<0.05 and ##p<0.01.

Figure 3. Curcumin treatment induces expression of UCP1 protein. 3T3-L1 and primary white adipocytes after curcumin treatment were fixed with p-formaldehyde, subjected to staining for Mito® Tracker Red, and then ICC staining for UCP1. The immunofluorescent images were captured at X400 and X800 magnifications.

Figure 4. Curcumin treatment results in mitochondrial biogenesis. Representative transmission electronic microscopic images from and 3T3-L1 and primary white adipocytes treated with curcumin (A). Protein expression levels of CPT, HSL, p-ACC, and cytochrome 24

ACCEPTED MANUSCRIPT C in 3T3-L1 and primary white adipocytes treated with curcumin (B). Expression levels were measured by densitometric analysis, and protein levels were normalized with β-Actin. Oil Red O staining was performed to depict maturation of both 3T3-L1 and primary white

T

adipocytes. Curcumin treatment increases number of small lipid droplets (C). All data are

RI P

presented as the mean ±SD, and differences between groups were determined by One-way Analysis of Variance (ANOVA) using the Statistical Package of Social Science (SPSS,

SC

version 17.0; SPSS Inc., Chicago, IL, USA) program, followed by Tukey’s post hoc tests. Statistical significance between control and curcumin-treatment groups was shown as p<0.05 and **p<0.01; between cocktail and curcumin-treated groups was depicted as †p<0.05

*

MA NU

and ††p<0.01; between control and cocktail was noted as #p<0.05 and ##p<0.01.

Figure 5. Curcumin activates AMPK. AMPK was significantly phosphorylated and the ratio of p-AMPK to AMPK indicated increased levels upon curcumin treatment in both 3T3-L1 and primary white adipocytes. Expression levels were measured by densitometric analysis,

ED

and proteins were normalized with β-actin. All data are presented as the mean ±SD, and differences between groups were determined by One-way Analysis of Variance (ANOVA)

PT

using the Statistical Package of Social Science (SPSS, version 17.0; SPSS Inc., Chicago, IL, USA) program, followed by Tukey’s post hoc tests. Statistical significance between control

CE

and curcumin-treatment groups was shown as *p<0.05 and †

**

p<0.01; between cocktail and

††

curcumin-treated groups was depicted as p<0.05 and p<0.01; between control and cocktail

AC

was noted as #p<0.05 and ##p<0.01.

Figure 6. Effect of AICAR and dorsomorphin on expression of browning marker proteins. AICAR (1 mM) and dorsomorphin (5 mM) were treated to adipocytes, and protein expression levels were determined by Western blotting.

Figure 7. Suggested pathway for curcumin-induced fat browning via AMPK-mediated pathway: (→) stimulatory, (┴) inhibitory action, (↑) up-regulation.

25

Figure 1

AC

CE

PT

ED

MA NU

SC

RI P

T

ACCEPTED MANUSCRIPT

26

AC

CE

PT

ED

MA NU

SC

RI P

T

ACCEPTED MANUSCRIPT

Figure 2 27

AC

CE

PT

ED

MA NU

SC

RI P

T

ACCEPTED MANUSCRIPT

Figure 3

28

AC

CE

PT

ED

MA NU

SC

RI P

T

ACCEPTED MANUSCRIPT

Figure 4 29

MA NU

SC

RI P

T

ACCEPTED MANUSCRIPT

AC

CE

PT

ED

Figure 5

30

MA NU

SC

RI P

T

ACCEPTED MANUSCRIPT

AC

CE

PT

ED

Figure 6

31

MA NU

SC

RI P

T

ACCEPTED MANUSCRIPT

AC

CE

PT

ED

Figure 7

32